JPM26: OpenEvidence makes the case for AI-powered 'medical super-intelligence'
SAN FRANCISCO—Advances in agentic AI will enable a system of AI agents that can be subspecialists in clinical areas, OpenEvidence co-founder Daniel Nadler, Ph.D., said at the annual J.P. Morgan Healthcare Conference.